The Challenge to Deliver Oxaliplatin (l-OHP) to Solid Tumors: Development of Liposomal l-OHP Formulations.

Matsuo, Nana Cristina Amorim; Ando, Hidenori; Doi, Yusuke; Shimizu, Taro; Ishima, Yu; Ishida, Tatsuhiro

Matsuo, Nana Cristina Amorim; Ando, Hidenori; Doi, Yusuke; Shimizu, Taro; Ishima, Yu; Ishida, Tatsuhiro.

Afiliação

Matsuo NCA; Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University.
Ando H; Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University.
Doi Y; Formulation Research Laboratory, CMC Division, Taiho Pharmaceutical Co., Ltd.
Shimizu T; Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University.
Ishima Y; Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University.
Ishida T; Department of Pharmacokinetics and Biopharmaceutics, Institute of Biomedical Sciences, Tokushima University.

Chem Pharm Bull (Tokyo) ; 70(5): 351-358, 2022.

Article em En | MEDLINE | ID: mdl-35491191

Assuntos

Antineoplásicos; Neoplasias Colorretais; Antineoplásicos/uso terapêutico; Neoplasias Colorretais/tratamento farmacológico; Humanos; Lipossomos; Compostos Organoplatínicos/uso terapêutico; Oxaliplatina; Polietilenoglicóis

Palavras-chave

PEGylated liposome; cancer therapy; drug delivery system (DDS); oxaliplatin (l-OHP)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google